BNTC Benitec Biopharma

Benitec Biopharma Ltd is a biotechnology company which develops therapeutic technology platform that combines gene silencing and gene therapy which cures disease causing genes from single administration.

As of 09/30/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Australia
Country of incorporation:  USA
IPO date:  06/23/2014
Outstanding shares:  8,171,690
Average volume:  720,152
Market cap:   $2,900,950
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -0.18
PB ratio:   0.40
PS ratio:   37.65
Return on equity:   -227.98%
Net income %:   -22,252.80%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy